Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nova Mentis Life Science Corp. C.LIB

Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Comment by TenFingerson Jul 04, 2018 11:39am
65 Views
Post# 28267260

RE:Pet lovers. Lib better get off the pot.

RE:Pet lovers. Lib better get off the pot.Yep - the window of opportunity will close as larger players corner this market as well. LIB needs to get moving. A news release on June 1, 2017 stated that the first trial would take 6-8 months. This actually would have been EXCELLENT timing if we could actually deliver anything on time. We would actually have a hand to play at this point as other licensed producers start devoting 10% or so of their production to this pet market and beat us to our own end.

I'm amazed how other companies in the sector are so agile that they can spin on a dime, yet anything we decide to do seems to be drawn out for so long. By the time Lib has their formula licensed with HC, there will be 50 other companies doing this. This shold have been a Q1-Q2 target.

Every day that passes in silence at this point is making their strategy more and more difficult to execute on. If I was Will I'd be on the phone daily with ESEV. I'd also be watching over those contractors' shoulders. This is getting ridiculous.

Punishment will continue on the SP until we see something tangible.
 

June 1, 2017:

"First Clinical Trial Details 

The study will include large mixed-breed dogs, which will receive the drug or placebos in the active phase of study, with the timeline to finish the activity estimated at between six to eight months. The focus will be on treating chronic pain due to hip dysplasia, and/or elbow dysplasia, or stifle DJD due to Canine Cruciate Ligament Disease (CCLD)."



RetiredGolfer wrote: https://www.680news.com/video/2018/07/03/cannabis-companies-preparing-for-pet-market/


<< Previous
Bullboard Posts
Next >>